| Micro-managing the circadian clock: The role of microRNAs in biological timekeeping N Mehta, HYM Cheng Journal of molecular biology 425 (19), 3609-3624, 2013 | 107 | 2013 |
| The proteomic landscape of the suprachiasmatic nucleus clock reveals large-scale coordination of key biological processes CK Chiang, N Mehta, A Patel, P Zhang, Z Ning, J Mayne, WYL Sun, ... PLoS genetics 10 (10), e1004695, 2014 | 71 | 2014 |
| Cell surface expression of 78-kDa glucose-regulated protein (GRP78) mediates diabetic nephropathy R Van Krieken, N Mehta, T Wang, M Zheng, R Li, B Gao, E Ayaub, K Ask, ... Journal of Biological Chemistry 294 (19), 7755-7768, 2019 | 45 | 2019 |
| Phosphoproteome profiling reveals circadian clock regulation of posttranslational modifications in the murine hippocampus CK Chiang, B Xu, N Mehta, J Mayne, WYL Sun, K Cheng, Z Ning, J Dong, ... Frontiers in neurology 8, 110, 2017 | 37 | 2017 |
| Follistatin protects against glomerular mesangial cell apoptosis and oxidative stress to ameliorate chronic kidney disease N Mehta, AL Gava, D Zhang, B Gao, JC Krepinsky Antioxidants & redox signaling 31 (8), 551-571, 2019 | 35 | 2019 |
| The caveolin-1 regulated protein follistatin protects against diabetic kidney disease D Zhang, AL Gava, R Van Krieken, N Mehta, R Li, B Gao, EM Desjardins, ... Kidney international 96 (5), 1134-1149, 2019 | 23 | 2019 |
| Raf kinase inhibitory protein (RKIP): functional pleiotropy in the mammalian brain HH Ling, L Mendoza-Viveros, N Mehta, HYM Cheng Critical Reviews™ in Oncogenesis 19 (6), 2014 | 22 | 2014 |
| The emerging role of activins in renal disease N Mehta, JC Krepinsky Current opinion in nephrology and hypertension 29 (1), 136-144, 2020 | 19 | 2020 |
| GRK2 fine-tunes circadian clock speed and entrainment via transcriptional and post-translational control of PERIOD proteins N Mehta, AH Cheng, CK Chiang, L Mendoza-Viveros, HH Ling, A Patel, ... Cell reports 12 (8), 1272-1288, 2015 | 19 | 2015 |
| Inhibition of SREBP with fatostatin does not attenuate early diabetic nephropathy in male mice R Van Krieken, M Marway, P Parthasarathy, N Mehta, AJ Ingram, B Gao, ... Endocrinology 159 (3), 1479-1495, 2018 | 18 | 2018 |
| Caveolin-1 regulation of Sp1 controls production of the antifibrotic protein follistatin in kidney mesangial cells N Mehta, D Zhang, R Li, T Wang, A Gava, P Parthasarathy, B Gao, ... Cell Communication and Signaling 17, 1-16, 2019 | 15 | 2019 |
| miR299a-5p promotes renal fibrosis by suppressing the antifibrotic actions of follistatin N Mehta, R Li, D Zhang, A Soomro, J He, I Zhang, M MacDonald, B Gao, ... Scientific reports 11 (1), 88, 2021 | 7 | 2021 |
| Preclinical development and characterization of novel adeno-associated viral vectors for the treatment of lipoprotein lipase deficiency N Mehta, R Gilbert, PS Chahal, MJ Moreno, N Nassoury, N Coulombe, ... Human Gene Therapy 34 (17-18), 927-946, 2023 | 5 | 2023 |
| Sun-189 Follistatin protects against ER stress-induced oxidative stress and apoptosis both in vitro and in vivo in CKD N Mehta, A Gava, D Zhang, B Gao, J KREPINSKY Kidney International Reports 4 (7), S237, 2019 | 1 | 2019 |
| Gene Editing/Gene Therapies: PRECLINICAL EXPLORATION OF NOVEL ROUTES OF ADMINISTRATION FOR AN ADENO-ASSOCIATED VIRUS-BASED GENE THERAPY FOR THE TREATMENT OF LIPOPROTEIN LIPASE … N Mehta, R Gilbert, P Chahal, M Moreno, N Nassoury, N Coulombe, ... Cytotherapy 25 (6), S265, 2023 | | 2023 |
| SUN-188 FOLLISTATIN IS A NOVEL THERAPEUTIC AGENT IN CHRONIC KIDNEY DISEASE N Mehta, D Zhang, J He, R van Krieken, B Gao, J KREPINSKY Kidney International Reports 4 (7), S236-S237, 2019 | | 2019 |
| Molecular Regulation of Follistatin by Caveolin-1 in Glomerular Mesangial Cells and its Therapeutic Potential in Chronic Kidney Disease N Mehta | | 2019 |
| G-protein Coupled Receptor Kinase 2 and Murine Circadian Clock Regulation N Mehta University of Toronto (Canada), 2014 | | 2014 |
